Furthermore, an increased albumin-to-fibrinogen ratio (AFR) has been linked to poor prognosis in several cancer types including lung cancer (Hamanaka et al., 2019), bladder cancer (Li et al., 2021) and colorectal cancer (Xie et al., 2022). This evidence concerns the gene ALB and lung carcinoma.